Good morning, grinders. Yesterday was another reminder that when companies actually deliver, markets reward them—hard. Here’s your fast recap and what to watch as we head into Thursday’s open.
Market Pulse
U.S. futures edged higher overnight as investors braced for fresh Q2 results after AMD and Novo set the tone. Equities drifted into modest gains with semiconductor and health-care names drawing early bids.
Key Movers
AMD's pending report and expectations that Novo will unveil cost-cutting plans have traders leaning into tech and pharma names. Meanwhile, Bitcoin’s slide under $115,800 ignited chatter about weakening risk appetite among crypto traders (CryptoSlate).
Macro & Politics
Emerging-market jitters surfaced as funds trimmed positions in Itau Unibanco and reshuffled stakes in CF Industries, pointing to caution beyond U.S. borders (ETF Daily News). Geopolitical heat remains off radar for now.
What’s Next
All eyes shift to CompoSecure’s Q2 print on Thursday and any fresh commentary on Fed intentions will steer market direction at the open.
Market Commentary
Everyone’s cheering overnight gains ahead of AMD and Novo, but they’re ignoring that short interest in the Fidelity Disruptive Automation ETF (NASDAQ: FBOT) jumped 90.6% in July (ETF Daily News). If the crowd is piling into automation on hype alone, watch for a squeeze crash that could drag down tech names beyond the headline small caps.
Across at GlobeNewswire, the Alzheimer's DMT market is set to shift dynamics as late-stage trials stack up through 2030—yet biotech investors are still hunting the next Axon Pharmaceuticals-style breakout. This disconnect between R&D runway and actual market catalysts shows too many traders worshipping buzz instead of fundamentals.
Stop dancing to rumor-driven moves and start focusing on real earnings catalysts. With CompoSecure reporting Q2 tomorrow (ETF Daily News) and integration risks looming in the Alcon-STAAR deal, position size matters more than hero bets—protect gains before new spin-up starts.
📈 Breaking Financial News
Explore the growth potential of the Alzheimer's disease-modifying therapies (DMTs) market as lecanemab gains FDA approval in 2023. With several late-stage trials underway, anticipate market shifts through 2030. Analyze global trends, revenue forecasts, and em…
Mackenzie Financial Corp cut its position in Itau Unibanco Holding S.A. (NYSE:ITUB – Free Report) by 20.1% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 179,521 shares of t…
AI empowers companies to uncover niche markets with high potential, using data-driven insights to find untapped opportunities.
Mackenzie Financial Corp raised its stake in shares of CommScope Holding Company, Inc. (NASDAQ:COMM – Free Report) by 1,203.4% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 163,767 shares of the communications equi…
I'm a Futurist: Here are 4 stocks better than Nvidia
Nvidia's own customers could soon become fierce competitors, dethroning the AI Chip King. But there's a critical component that AI data centers need just as badly as chips. The demand is so massive that a single data center uses enough of it to stretch around the earth eight times. While the media hypes up AI chips, the smart money has found the next big thing. Discover Futurist Eric Fry's “Nvidia-killer” stock ideas. Click here for a complete analysis
🔍 Market Analysis & Insights
Vontier (NYSE:VNT – Free Report) had its price objective lifted by UBS Group from $47.00 to $50.00 in a research report released on Tuesday,Benzinga reports. The brokerage currently has a buy rating on the stock. A number of other research firms also recently…
The electric vehicle maker now anticipates producing between 18,000 and 20,000 vehicles for the year after previously projecting a goal of 20,000.
Interface, Inc. (NASDAQ:TILE – Get Free Report) shares gapped up prior to trading on Friday after the company announced better than expected quarterly earnings. The stock had previously closed at $20.62, but opened at $23.97. Interface shares last traded at $…
Fidelity Disruptive Automation ETF (NASDAQ:FBOT – Get Free Report) was the target of a significant increase in short interest in the month of July. As of July 15th, there was short interest totaling 6,100 shares, anincreaseof90.6% from the June 30th total of …
Investors’ appetite for risk seems to weaken as Bitcoin (BTC) signals weakness and altcoin traders capitulate. According to the latest edition of the Bitfinex Alpha report, BTC slipped below its three-week range floor near $115,800 late last week. On August 5…
TRUMP WAS RIGHT: “AMERICAN INNOVATION WILL DOMINATE THE WORLD”
While China builds cheap knockoffs, American companies are building the FUTURE. Tesla. Waymo. The robotaxi revolution is 100% MADE IN AMERICA. And it's about to CRUSH foreign competition and create the biggest wealth transfer in history. Marc Lichtenfeld shows you how to profit from American technological dominance. Bet on America. Bet on the future. Get rich.
💰 Investment Opportunities
Mackenzie Financial Corp raised its position in CF Industries Holdings, Inc. (NYSE:CF – Free Report) by 42.4% during the first quarter, HoldingsChannel reports. The firm owned 10,408 shares of the basic materials company’s stock after buying an additional 3,0…
CompoSecure (NASDAQ:CMPO – Get Free Report) will likely be releasing its Q2 2025 earnings data after the market closes on Thursday, August 7th. Analysts expect CompoSecure to post earnings of $0.21 per share and revenue of $110.51 million for the quarter. Com…
CA Rudramurthy BV suggests Nifty and Bank Nifty are currently weak, advising against shorting now. He recommends focusing on stocks with relative strength, highlighting Indian Hotels with a target of Rs 800 and IndiGo with a target of Rs 6,000. He suggests be…
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
If your house isn’t selling, there are plenty of potential reasons. Here are 10 reasons your house isn’t selling, practical solutions and additional tips. The post Why is My House Not Selling? 10 Reasons and Solutions to Help appeared first on Redfin | Real E…
Terrifying reason Trump killed the U.S. penny?
You see, the U.S. is facing a looming shortage that could cripple the economy with runaway inflation… and send one tiny clutch of investments soaring in the weeks ahead. Former White House Advisor, Jim Rickards, just came forward to share this startling story.
